Trial · NCT03447249
Results by group42
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 42
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Absolute Change in Percent Predicted Forced Expiratory Volume in 1 Second (ppFEV1) | Placebo | -1.0 | Standard Error 0.6 | percentage points | |
| Absolute Change in Percent Predicted Forced Expiratory Volume in 1 Second (ppFEV1) | VX-659/TEZ/IVA TC | 13.0 | Standard Error 0.6 | percentage points | |
| Absolute Change in Percent Predicted Forced Expiratory Volume in 1 Second (ppFEV1) | Placebo | -0.8 | Standard Error 0.6 | percentage points | |
| Absolute Change in Percent Predicted Forced Expiratory Volume in 1 Second (ppFEV1) | VX-659/TEZ/IVA TC | 13.4 | Standard Error 0.6 | percentage points | |
| Number of Pulmonary Exacerbations (PEx) | Placebo | 116 | pulmonary exacerbation events | ||
| Number of Pulmonary Exacerbations (PEx) | VX-659/TEZ/IVA TC | 17 | pulmonary exacerbation events | ||
| Absolute Change in Sweat Chloride (SwCl) | Placebo | -0.1 | Standard Error 1.0 | millimole per liter (mmol/L) | |
| Absolute Change in Sweat Chloride (SwCl) | VX-659/TEZ/IVA TC | -44.6 | Standard Error 0.9 | millimole per liter (mmol/L) | |
| Absolute Change in Cystic Fibrosis Questionnaire Revised (CFQ-R) Respiratory Domain Score | Placebo | -1.5 | Standard Error 1.1 | units on a scale | |
| Absolute Change in Cystic Fibrosis Questionnaire Revised (CFQ-R) Respiratory Domain Score | VX-659/TEZ/IVA TC | 18.6 | Standard Error 1.0 | units on a scale | |
| Absolute Change in Body Mass Index (BMI) | Placebo | -0.05 | Standard Error 0.07 | kilogram per meter square (kg/m^2) | |
| Absolute Change in Body Mass Index (BMI) | VX-659/TEZ/IVA TC | 1.06 | Standard Error 0.07 | kilogram per meter square (kg/m^2) | |
| Absolute Change in Sweat Chloride | Placebo | 0.0 | Standard Error 1.0 | mmol/L | |
| Absolute Change in Sweat Chloride | VX-659/TEZ/IVA TC | -43.3 | Standard Error 1.0 | mmol/L | |
| Absolute Change in Cystic Fibrosis Questionnaire Revised (CFQ-R) Respiratory Domain Score | Placebo | 0.1 | Standard Error 1.2 | units on a scale | |
| Absolute Change in Cystic Fibrosis Questionnaire Revised (CFQ-R) Respiratory Domain Score | VX-659/TEZ/IVA TC | 18.0 | Standard Error 1.2 | units on a scale | |
| Time-to-first Pulmonary Exacerbation (PEx) | Placebo | NA | 95% Confidence Interval NA to NA | days | |
| Time-to-first Pulmonary Exacerbation (PEx) | VX-659/TEZ/IVA TC | NA | 95% Confidence Interval NA to NA | days | |
| Absolute Change in BMI Z-score for Participants <=20 Years of Age at Baseline | Placebo | -0.08 | Standard Error 0.05 | kg/m^2 | |
| Absolute Change in BMI Z-score for Participants <=20 Years of Age at Baseline | VX-659/TEZ/IVA TC | 0.31 | Standard Error 0.05 | kg/m^2 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03447249/results